Captions are auto-generated. An enhanced dermatologic management (DM) strategy, COCOON DM, significantly reduced the incidence and …
NSCLC
-
-
Cemiplimab monotherapy provided durable survival benefits compared with chemotherapy for people with advanced non–small cell lung …
-
Uncommon EGFR mutations, such as exon 20 insertions, compound variants, and P-loop αC-helix compressing (Pacc) alterations, …
-
Osimertinib Plus Chemo in EGFR-Mutated NSCLC | Image Credit: © Ashling Wahner & MJH Life Sciences …
-
The FDA granted a breakthrough therapy designation to izalontamab brengitecan (iza-bren, formerly BL-B01D1; Bristol Myers Squibb, …
-
In part 2 of an interview with The American Journal of Managed Care®Julia Rotow, MD, Dana-Farber …
-
The FDA maintained its momentum in July, issuing a wave of drug approvals across diverse therapeutic …
-
“`html Biomarker Testing Improves Outcomes in Early-Stage Lung cancer Biomarker testing Substantially Improves Outcomes in Early-Stage …
